First non-ATP competitive glycogen synthase kinase 3 β (GSK-3β) inhibitors: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease

Journal of Medicinal Chemistry

Volumn 45, Issue 6, 2002, Pages 1292-1299

  Martinez, Ana ^a   Alonso, Mercedes ^a   Castro, Ana ^a   Pérez, Concepción ^a   Moreno, Francisco J ^b  

^a INSTITUTO DE QUÍMICA MÉDICA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA INHIBITOR; THIADIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; DRUG SYNTHESIS; DRUG USE; NEUROFIBRILLARY TANGLE; STRUCTURE ACTIVITY RELATION;

ADENOSINE TRIPHOSPHATE; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMALS; BINDING, COMPETITIVE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASES; HUMANS; MOLECULAR SEQUENCE DATA; RABBITS; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; THIADIAZOLES;

EID: 0037075791     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm011020u     Document Type: Article

References (36)

1. Neurofibrillary tangles and tau phosphorylation
2. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments
3. Sites of phosphorylation in tau and factors affecting their regulation
4. Tau protein as a therapeutic target in Alzheimer's disease and other neurodegenerative disorders
5. Inhibition of tau phosphorylation: A new therapeutic strategy for the treatment of Alzheimer's disease and other neurodegenerative disorders
6. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease
7. Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants
8. Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in teh central nervous system of human four-repeat tau transgenic mice
9. Does dysregullation of the notch and wingless/Wnt pathways underlie the pathogenesis of Alzheimer's disease?
10. Presenilin 1 associates with glycogen synthase kinase 3-beta and its substrate tau
11. Effect of increased glycogen synthase kinase-3 activity upon the maturation of the amyloid precursor protein in transfected cells
12. GSK-3: New thoughts on an old enzyme
13. Expression analysis of glycogen synthase kinase-3 in human tissues
14. Decreased nuclear β-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3β conditional transgenic mice
15. Structure of GSK-3beta reveals a primed phosphorylation mechanism
16. Crystal structure of glycogen synthase kinase 3β: Structural basis for phosphate-primed substrate specificity and autoinhibition
17. A common phosphate binding site explains the unique specificity of GSK-3 and its inactivation by phophorylation
18. Regulation of GSK-3: A cellular multiprocessor
19. Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons
20. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons
21. The protein kinase C inhibitors bisindolylmaleimide I (GF 109203x) and IX (Ro 318220) are potent inhibitors of glycogen synthase kinase-3 activity
22. 3-Anilino-4-arylmeleimides: Potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3)
23. Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25
24. Indirubins inhibit glycogen synthase kinase-3 beta and cdk5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
25. Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent
26. Chlorination of isothiocyanates. III. N-aryl and N-alkyl-S-chloroisothiocarbamoyl chlorides with isocyantes. Synthesis of 1,2,4-thiadiazolidine-3,5-diones
27. Arylimino-l,2,4-thiadiazolidinones: A new family of potassium channel openers
28. Synthesis and potential muscarinic receptor binding and antioxidant properties of 3-(thiazolyl)pyridine 1-oxides compounds
29. N-benzylpiperidine derivatives of 1,2,4-thiadiazolidinone as new acetylcholinesterase inhibitors
30. The reactions of 5-amino-1,2,3,4-thiatriazoles with isocyanates
31. Use of peptides for affinity purification of protein-serine kinases
32. ATP-sited-directed competitive and irreversible inhibitors of protein kinases
33. Identification of a protein that interact with tubulin dimers and increases the catastrophe rate of microtubule
34. 2+-dependent hydrophobic-interaction chromatography. Isolation of a novel Ca2+-binding protein and protein kinase C from bovine brain
35. An improved purification procedure and properties of casein kinase II from brain